Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignant hyperthermia

R Ben Abraham1, P Adnet, V Glauber

  • 1Department of Anaesthesia and Intensive Care, Chaim Sheba Medical Center, Tel Hashomer, Israel.

Postgraduate Medical Journal
|April 16, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tolerance's improvement of flexible bronchoscopy by Ericksonian hypnosis: The BREATH study.

Respiratory medicine and research·2022
Same author

Correction to: The oxygen reserve index (ORI): a new tool to monitor oxygen therapy.

Journal of clinical monitoring and computing·2018
Same author

Non-invasive multi-parametric cardiorespiratory assessment of the hemodynamically unstable patient.

Revista espanola de anestesiologia y reanimacion·2017
Same author

Perioperative goal-directed therapy with uncalibrated pulse contour methods: impact on fluid management and postoperative outcome.

British journal of anaesthesia·2017
Same author

The oxygen reserve index (ORI): a new tool to monitor oxygen therapy.

Journal of clinical monitoring and computing·2017
Same author

[Annual meeting of the European Malignant Hyperthermia Group].

Harefuah·2011
Same journal

Dapagliflozin-induced anaphylactic shock.

Postgraduate medical journal·2026
Same journal

Comparative efficacy of Janus kinase inhibitors in severe alopecia areata: a network meta-analysis based on randomized controlled trials.

Postgraduate medical journal·2026
Same journal

Two cases of toxic epidermal necrolysis with severe ocular involvement treated with adjunctive tofacitinib.

Postgraduate medical journal·2026
Same journal

Diastolic dysfunction and diabetes: the DIADAD study-a retrospective cohort study from Liverpool.

Postgraduate medical journal·2026
Same journal

Care, cash, and proof: forensic accountability for war-related starvation.

Postgraduate medical journal·2026
Same journal

Response to traumatic injuries in polo players in England.

Postgraduate medical journal·2026
See all related articles

Malignant hyperthermia (MH) is a rare genetic disorder triggered by anesthesia. Prompt recognition, avoidance of triggering agents, and dantrolene treatment are crucial for managing MH episodes and preventing fatal outcomes.

Area of Science:

  • Anesthesiology
  • Genetics
  • Pharmacology

Background:

  • Malignant hyperthermia (MH) is a rare, autosomal dominant genetic disorder.
  • It causes a hypermetabolic reaction in skeletal muscle upon exposure to specific anesthetic agents.
  • This reaction can lead to severe hyperthermia and rhabdomyolysis.

Purpose of the Study:

  • To outline the risks associated with malignant hyperthermia during anesthesia.
  • To detail essential precautions for susceptible patients.
  • To describe the primary treatment and diagnostic methods for MH.

Main Methods:

  • Review of clinical presentation and pathophysiology of MH.
  • Description of anesthetic triggering agents and their effects.
  • Explanation of preventative measures and dantrolene sodium treatment.

Related Experiment Videos

  • Discussion of the in vitro caffeine-halothane contracture test for susceptibility.

    • Main Results:

    • Susceptible individuals face significant danger from triggering anesthetic agents.
    • Prohibiting triggering agents, monitoring temperature and CO2, and having dantrolene available reduce MH risk.
    • Prompt recognition and treatment of MH episodes are vital for preventing mortality.

    Conclusions:

    • Malignant hyperthermia necessitates strict anesthetic precautions.
    • Dantrolene sodium is the primary treatment for MH.
    • The in vitro caffeine-halothane contracture test is the current gold standard for diagnosing MH susceptibility, with genetic testing anticipated in the future.